Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 3/2012

01.12.2012

Behçet Syndrome: Is It One Condition?

verfasst von: H. Yazici, S. Ugurlu, E. Seyahi

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Behçet's syndrome (BS) is a disease of unknown etiology, and as such, there have been efforts to classify BS within the popular nosological identities of the times such as seronegative spondarthritides, autoimmune, and more recently autoinflammatory diseases. Current evidence suggests that BS does not easily fit into any one of these lumps, while on occasion, it might be impossible to tell BS from Crohn's disease, especially when the main clinical presentation is intestinal ulceration. There are distinct regional differences in disease expression of BS with fewer cases of intestinal disease in the Mediterranean basin and less severe eye disease and less frequent skin pathergy among patients reported from northern Europe or America. The clustering of symptoms, especially with the recently described increased frequency of the acne/arthritis cluster in familial cases, suggests that more than one pathological pathway is involved in what we call BS today. Supportive evidence for this contention also comes from the observations that (a) the genetic component is very complex with perhaps different genetic modes of inheritance in the adult and in the pediatric patients; and (b) there are differing organ responses to one same drug. For example, the anti-TNF agents successfully control the oral ulcers while they have no effect on the pathergy reaction.
Literatur
1.
Zurück zum Zitat Kural-Seyahi E, Fresko I, Seyahi N et al (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76CrossRef Kural-Seyahi E, Fresko I, Seyahi N et al (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76CrossRef
2.
Zurück zum Zitat Yazici H (1978) Behcet's disease. Br Med J 2:952 Yazici H (1978) Behcet's disease. Br Med J 2:952
3.
Zurück zum Zitat Mizushima Y (1988) Recent research into Behçet's disease in Japan. Int J Tissue React 10:59–65PubMed Mizushima Y (1988) Recent research into Behçet's disease in Japan. Int J Tissue React 10:59–65PubMed
4.
Zurück zum Zitat Cheon JH, Celik AF, Kim W (2010) Behçet's disease: gastrointestinal involvement. In: Yazici Y, Yazici H (eds) Behçet's syndrome, 1st edn. Springer, New York, pp 165–189CrossRef Cheon JH, Celik AF, Kim W (2010) Behçet's disease: gastrointestinal involvement. In: Yazici Y, Yazici H (eds) Behçet's syndrome, 1st edn. Springer, New York, pp 165–189CrossRef
5.
Zurück zum Zitat International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078–1080 International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078–1080
6.
Zurück zum Zitat Moll JM, Haslock I, Macrae IF, Wright V (1974) Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome. Medicine (Baltimore) 53:343–364CrossRef Moll JM, Haslock I, Macrae IF, Wright V (1974) Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome. Medicine (Baltimore) 53:343–364CrossRef
7.
Zurück zum Zitat Yazici H, Tuzlaci M, Yurdakul S (1981) A controlled survey of sacroiliitis in Behcet's disease. Ann Rheum Dis 40:558–559PubMedCrossRef Yazici H, Tuzlaci M, Yurdakul S (1981) A controlled survey of sacroiliitis in Behcet's disease. Ann Rheum Dis 40:558–559PubMedCrossRef
8.
Zurück zum Zitat Yazici H, Chamberlain MA, Schreuder I, D'Amaro J, Muftuoglu M (1980) HLA antigens in Behçet's disease: a reappraisal by a comparative study of Turkish and British patients. Ann Rheum Dis 39:344–348PubMedCrossRef Yazici H, Chamberlain MA, Schreuder I, D'Amaro J, Muftuoglu M (1980) HLA antigens in Behçet's disease: a reappraisal by a comparative study of Turkish and British patients. Ann Rheum Dis 39:344–348PubMedCrossRef
9.
Zurück zum Zitat Ohno S, Aoki K, Sugiura S, Nakayama E, Itakura K, Aizawa M (1973) HL-A5 and Behcet's disease. Lancet 2:1383–1384CrossRef Ohno S, Aoki K, Sugiura S, Nakayama E, Itakura K, Aizawa M (1973) HL-A5 and Behcet's disease. Lancet 2:1383–1384CrossRef
10.
Zurück zum Zitat Diri E, Mat C, Hamuryudan V, Yurdakul S, Hizli N, Yazici H (2001) Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked study. Ann Rheum Dis 60:1074–1076PubMedCrossRef Diri E, Mat C, Hamuryudan V, Yurdakul S, Hizli N, Yazici H (2001) Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked study. Ann Rheum Dis 60:1074–1076PubMedCrossRef
11.
Zurück zum Zitat Tunc R, Keyman E, Melikoglu M, Fresko I, Yazici H (2002) Target organ associations in Turkish patients with Behçet's disease: a cross sectional study by exploratory factor analysis. J Rheumatol 29:2393–2396PubMed Tunc R, Keyman E, Melikoglu M, Fresko I, Yazici H (2002) Target organ associations in Turkish patients with Behçet's disease: a cross sectional study by exploratory factor analysis. J Rheumatol 29:2393–2396PubMed
12.
Zurück zum Zitat Hatemi G, Bahar H, Uysal S et al (2004) The pustular skin lesions in Behcet's syndrome are not sterile. Ann Rheum Dis 63:1450–1452PubMedCrossRef Hatemi G, Bahar H, Uysal S et al (2004) The pustular skin lesions in Behcet's syndrome are not sterile. Ann Rheum Dis 63:1450–1452PubMedCrossRef
13.
Zurück zum Zitat Hatemi G, Fresko I, Tascilar K, Yazici H (2008) Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum 58:1539–1545PubMedCrossRef Hatemi G, Fresko I, Tascilar K, Yazici H (2008) Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum 58:1539–1545PubMedCrossRef
14.
Zurück zum Zitat Hatemi G, Fresko I, Yurdakul S et al (2010) Reply to letter by Priori et al commenting on whether Behçet's syndrome patients with acne and arthritis comprise a true subset. Arthritis Rheum 62:305–306PubMedCrossRef Hatemi G, Fresko I, Yurdakul S et al (2010) Reply to letter by Priori et al commenting on whether Behçet's syndrome patients with acne and arthritis comprise a true subset. Arthritis Rheum 62:305–306PubMedCrossRef
15.
Zurück zum Zitat Karaca M, Hatemi G, Sut N, Yazici H (2012) The papulopustular lesion/arthritis cluster of Behcet's syndrome also clusters in families. Rheumatology (Oxford) 27. doi:10.1093/rheumatology/ker423 Karaca M, Hatemi G, Sut N, Yazici H (2012) The papulopustular lesion/arthritis cluster of Behcet's syndrome also clusters in families. Rheumatology (Oxford) 27. doi:10.​1093/​rheumatology/​ker423
16.
Zurück zum Zitat Krause I, Leibovici L, Guedj D, Molad Y, Uziel Y, Weinberger A (1999) Disease patterns of patients with Behçet's disease demonstrated by factor analysis. Clin Exp Rheumatol 17:347–350PubMed Krause I, Leibovici L, Guedj D, Molad Y, Uziel Y, Weinberger A (1999) Disease patterns of patients with Behçet's disease demonstrated by factor analysis. Clin Exp Rheumatol 17:347–350PubMed
17.
Zurück zum Zitat Tunc R, Saip S, Siva A, Yazici H (2004) Cerebral venous thrombosis is associated with major vessel disease in Behçet's syndrome. Ann Rheum Dis 63:1693–1694PubMedCrossRef Tunc R, Saip S, Siva A, Yazici H (2004) Cerebral venous thrombosis is associated with major vessel disease in Behçet's syndrome. Ann Rheum Dis 63:1693–1694PubMedCrossRef
18.
Zurück zum Zitat Seyahi E, Melikoglu M, Akman C et al (2012) Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients. Medicine (Baltimore) 91:35–48CrossRef Seyahi E, Melikoglu M, Akman C et al (2012) Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients. Medicine (Baltimore) 91:35–48CrossRef
19.
Zurück zum Zitat Uzun O, Akpolat T, Erkan L (2005) Pulmonary vasculitis in Behcet disease: a cumulative analysis. Chest 127:2243–2253PubMedCrossRef Uzun O, Akpolat T, Erkan L (2005) Pulmonary vasculitis in Behcet disease: a cumulative analysis. Chest 127:2243–2253PubMedCrossRef
20.
Zurück zum Zitat Melikoglu M, Ugurlu S, Tascilar K et al (2008) Large vessel involvement in Behcet's syndrome: a retrospective survey. Ann Rheum Dis 67(Suppl 2):67 Melikoglu M, Ugurlu S, Tascilar K et al (2008) Large vessel involvement in Behcet's syndrome: a retrospective survey. Ann Rheum Dis 67(Suppl 2):67
21.
Zurück zum Zitat Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 14:426–430PubMedCrossRef Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 14:426–430PubMedCrossRef
22.
Zurück zum Zitat Yazici H (1997) The place of Behçet's syndrome among the autoimmune diseases. Int Rev Immunol 14:1–10PubMedCrossRef Yazici H (1997) The place of Behçet's syndrome among the autoimmune diseases. Int Rev Immunol 14:1–10PubMedCrossRef
23.
Zurück zum Zitat Oran M, Hatemi G, Tasli L et al (2008) Behçet's syndrome is not associated with vitiligo. Clin Exp Rheumatol 26(Suppl 50):107–109 Oran M, Hatemi G, Tasli L et al (2008) Behçet's syndrome is not associated with vitiligo. Clin Exp Rheumatol 26(Suppl 50):107–109
24.
Zurück zum Zitat Seyahi E, Yazici H (2007) Atherosclerosis in Behçet's syndrome. Clin Exp Rheumatol 25(Suppl 45):1–5 Seyahi E, Yazici H (2007) Atherosclerosis in Behçet's syndrome. Clin Exp Rheumatol 25(Suppl 45):1–5
25.
Zurück zum Zitat Gül A (2005) Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4:81–83PubMedCrossRef Gül A (2005) Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4:81–83PubMedCrossRef
26.
Zurück zum Zitat Yazici H, Fresko I (2005) Behçet's disease and other autoinflammatory conditions: what's in a name? Clin Exp Rheumatol 23(Suppl 38):1–2 Yazici H, Fresko I (2005) Behçet's disease and other autoinflammatory conditions: what's in a name? Clin Exp Rheumatol 23(Suppl 38):1–2
27.
Zurück zum Zitat Kurokawa T, Kikuchi T, Ohta K, Imai H, Yoshimura N (2003) Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology 110:2040–2044PubMedCrossRef Kurokawa T, Kikuchi T, Ohta K, Imai H, Yoshimura N (2003) Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology 110:2040–2044PubMedCrossRef
28.
Zurück zum Zitat Toro JR, Aksentijevich I, Hull K, Dean J, Kastner DL (2000) Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations. Arch Dermatol 136:1487–1494PubMedCrossRef Toro JR, Aksentijevich I, Hull K, Dean J, Kastner DL (2000) Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations. Arch Dermatol 136:1487–1494PubMedCrossRef
29.
Zurück zum Zitat Dollfus H, Häfner R, Hofmann HM et al (2000) Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood. Arch Ophthalmol 118:1386–1392PubMedCrossRef Dollfus H, Häfner R, Hofmann HM et al (2000) Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood. Arch Ophthalmol 118:1386–1392PubMedCrossRef
30.
Zurück zum Zitat Shimizu T, Ehrlich GE, Inaba G, Hayashi K (1979) Behçet's disease (Behçet's syndrome). Semin Arthritis Rheum 8:223–260PubMedCrossRef Shimizu T, Ehrlich GE, Inaba G, Hayashi K (1979) Behçet's disease (Behçet's syndrome). Semin Arthritis Rheum 8:223–260PubMedCrossRef
31.
Zurück zum Zitat Chang HK, Kim JW (2002) The clinical features of Behçet's disease in Yongdong district: analysis of a cohort followed from 1997 to 2001. J Korean Med Sci 17:784–789PubMed Chang HK, Kim JW (2002) The clinical features of Behçet's disease in Yongdong district: analysis of a cohort followed from 1997 to 2001. J Korean Med Sci 17:784–789PubMed
32.
Zurück zum Zitat Yurdakul S, Tuzuner N, Yurdakul I, Hamuryudan V, Yazici H (1996) Gastrointestinal involvement in Behçet's syndrome: a controlled study. Ann Rheum Dis 55:208–210PubMedCrossRef Yurdakul S, Tuzuner N, Yurdakul I, Hamuryudan V, Yazici H (1996) Gastrointestinal involvement in Behçet's syndrome: a controlled study. Ann Rheum Dis 55:208–210PubMedCrossRef
33.
Zurück zum Zitat Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M (2004) Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 138:373–380PubMedCrossRef Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M (2004) Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 138:373–380PubMedCrossRef
34.
Zurück zum Zitat Salvarani C, Pipitone N, Catanoso MG et al (2007) Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum 57:171–178PubMedCrossRef Salvarani C, Pipitone N, Catanoso MG et al (2007) Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum 57:171–178PubMedCrossRef
35.
Zurück zum Zitat Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM (2009) Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study. Arthritis Rheum 61:600–604PubMedCrossRef Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM (2009) Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study. Arthritis Rheum 61:600–604PubMedCrossRef
36.
Zurück zum Zitat Yazici Y, Filopoulos MT, Schimmel E, McCraken A, Swearingen C (2010) Clinical characteristics, treatment and ethnic/racial differences in the manifestations of 518 Behcet's syndrome patients in the United States. Arthritis Rheum 62(Suppl 10):535 Yazici Y, Filopoulos MT, Schimmel E, McCraken A, Swearingen C (2010) Clinical characteristics, treatment and ethnic/racial differences in the manifestations of 518 Behcet's syndrome patients in the United States. Arthritis Rheum 62(Suppl 10):535
37.
Zurück zum Zitat Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y (2011) Characteristics of vascular involvement in Behçet's disease in Japan: a retrospective cohort study. Clin Exp Rheumatol 29(Suppl 67):47–53 Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y (2011) Characteristics of vascular involvement in Behçet's disease in Japan: a retrospective cohort study. Clin Exp Rheumatol 29(Suppl 67):47–53
38.
Zurück zum Zitat Han JK, Kim HK, Kim YJ et al (2009) Behçet's disease as a frequently unrecognized cause of aortic regurgitation: suggestive and misleading echocardiography findings. J Am Soc Echocardiogr 22:1269–1274PubMedCrossRef Han JK, Kim HK, Kim YJ et al (2009) Behçet's disease as a frequently unrecognized cause of aortic regurgitation: suggestive and misleading echocardiography findings. J Am Soc Echocardiogr 22:1269–1274PubMedCrossRef
39.
Zurück zum Zitat Huong DL, Wechsler B, Papo T et al (1997) Endomyocardial fibrosis in Behçet's disease. Ann Rheum Dis 56:205–208PubMedCrossRef Huong DL, Wechsler B, Papo T et al (1997) Endomyocardial fibrosis in Behçet's disease. Ann Rheum Dis 56:205–208PubMedCrossRef
40.
Zurück zum Zitat Yazici H, Tuzun Y, Pazarli H, Yalcin B, Yurdakul S, Muftuoglu A (1980) The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey. J Rheumatol 7:206–210PubMed Yazici H, Tuzun Y, Pazarli H, Yalcin B, Yurdakul S, Muftuoglu A (1980) The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey. J Rheumatol 7:206–210PubMed
41.
Zurück zum Zitat Houman MH, Neffati H, Braham A et al (2007) Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients. Clin Exp Rheumatol 25(Suppl 45):58–64 Houman MH, Neffati H, Braham A et al (2007) Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients. Clin Exp Rheumatol 25(Suppl 45):58–64
42.
Zurück zum Zitat Chamberlain MA (1977) Behçet's syndrome in 32 patients in Yorkshire. Ann Rheum Dis 36:491–499PubMedCrossRef Chamberlain MA (1977) Behçet's syndrome in 32 patients in Yorkshire. Ann Rheum Dis 36:491–499PubMedCrossRef
43.
Zurück zum Zitat Moore SB, O’Duffy JD (1986) Lack of association between Behçet's disease and major histocompatibility complex II antigens in an ethnically diverse North American Caucasoid patient group. J Rheumatol 13:771–773PubMed Moore SB, O’Duffy JD (1986) Lack of association between Behçet's disease and major histocompatibility complex II antigens in an ethnically diverse North American Caucasoid patient group. J Rheumatol 13:771–773PubMed
44.
Zurück zum Zitat Hamuryudan V, Mat C, Saip S et al (1998) Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128:443–450PubMed Hamuryudan V, Mat C, Saip S et al (1998) Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128:443–450PubMed
45.
Zurück zum Zitat Yurdakul S, Mat C, Tüzün Y et al (2001) A double-blind trial of colchicine in Behçet's syndrome. Arthritis Rheum 44:2686–2692PubMedCrossRef Yurdakul S, Mat C, Tüzün Y et al (2001) A double-blind trial of colchicine in Behçet's syndrome. Arthritis Rheum 44:2686–2692PubMedCrossRef
46.
Zurück zum Zitat Melikoglu M, Fresko I, Mat C et al (2005) Short-term trial of etanercept in Behcet's disease: a double blind, placebo controlled study. J Rheumatol 32:98–105PubMed Melikoglu M, Fresko I, Mat C et al (2005) Short-term trial of etanercept in Behcet's disease: a double blind, placebo controlled study. J Rheumatol 32:98–105PubMed
47.
Zurück zum Zitat Gül A, Tugal-Tutkun I, Dinarello CA et al (2012) Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. Ann Rheum Dis 71:563–566PubMedCrossRef Gül A, Tugal-Tutkun I, Dinarello CA et al (2012) Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. Ann Rheum Dis 71:563–566PubMedCrossRef
48.
Zurück zum Zitat Gül A, Inanç M, Ocal L, Aral O, Koniçe M (2000) Familial aggregation of Behcet's disease in Turkey. Ann Rheum Dis 59:622–625PubMedCrossRef Gül A, Inanç M, Ocal L, Aral O, Koniçe M (2000) Familial aggregation of Behcet's disease in Turkey. Ann Rheum Dis 59:622–625PubMedCrossRef
49.
Zurück zum Zitat Bird Stewart JA (1986) Genetic analysis of families of patients with Behçet's syndrome: data incompatible with autosomal recessive inheritance. Ann Rheum Dis 45:265–268PubMedCrossRef Bird Stewart JA (1986) Genetic analysis of families of patients with Behçet's syndrome: data incompatible with autosomal recessive inheritance. Ann Rheum Dis 45:265–268PubMedCrossRef
50.
Zurück zum Zitat Molinari N, Koné Paut I, Manna R, Demaille J, Daures JP, Touitou I (2003) Identification of an autosomal recessive mode of inheritance in paediatric Behçet's families by segregation analysis. Am J Med Genet A 122A:115–118PubMedCrossRef Molinari N, Koné Paut I, Manna R, Demaille J, Daures JP, Touitou I (2003) Identification of an autosomal recessive mode of inheritance in paediatric Behçet's families by segregation analysis. Am J Med Genet A 122A:115–118PubMedCrossRef
51.
Zurück zum Zitat Fresko I, Soy M, Hamuryudan V et al (1998) Genetic anticipation in Behcet's syndrome. Ann Rheum Dis 57:45–48PubMedCrossRef Fresko I, Soy M, Hamuryudan V et al (1998) Genetic anticipation in Behcet's syndrome. Ann Rheum Dis 57:45–48PubMedCrossRef
52.
Zurück zum Zitat Masatlioglu S, Seyahi E, Tahir Turanli E et al (2010) A twin study in Behçet's syndrome. Clin Exp Rheumatol 28(Suppl 60):62–66 Masatlioglu S, Seyahi E, Tahir Turanli E et al (2010) A twin study in Behçet's syndrome. Clin Exp Rheumatol 28(Suppl 60):62–66
53.
Zurück zum Zitat Seyahi E, Tahir Turanli E, Mangan MS et al (2010) The prevalence of Behçet's syndrome, familial Mediterranean fever, HLA-B51 and MEFV gene mutations among ethnic Armenians living in Istanbul, Turkey. Clin Exp Rheumatol 28(Suppl 60):67–75 Seyahi E, Tahir Turanli E, Mangan MS et al (2010) The prevalence of Behçet's syndrome, familial Mediterranean fever, HLA-B51 and MEFV gene mutations among ethnic Armenians living in Istanbul, Turkey. Clin Exp Rheumatol 28(Suppl 60):67–75
54.
Zurück zum Zitat Gül A, Hajeer AH, Worthington J, Barrett JH, Ollier WE, Silman AJ (2001) Evidence for linkage of the HLA-B locus in Behcet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum 44:239–240PubMedCrossRef Gül A, Hajeer AH, Worthington J, Barrett JH, Ollier WE, Silman AJ (2001) Evidence for linkage of the HLA-B locus in Behcet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum 44:239–240PubMedCrossRef
55.
Zurück zum Zitat Karasneh J, Gül A, Ollier WE, Silman AJ, Worthington J (2005) Whole-genome screening for susceptibility genes in multicase families with Behçet's disease. Arthritis Rheum 52:1836–1842PubMedCrossRef Karasneh J, Gül A, Ollier WE, Silman AJ, Worthington J (2005) Whole-genome screening for susceptibility genes in multicase families with Behçet's disease. Arthritis Rheum 52:1836–1842PubMedCrossRef
56.
Zurück zum Zitat Remmers EF, Cosan F, Kirino Y et al (2010) Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet 42:698–702PubMedCrossRef Remmers EF, Cosan F, Kirino Y et al (2010) Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet 42:698–702PubMedCrossRef
57.
Zurück zum Zitat Mizuki N, Meguro A, Ota M et al (2010) Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet 42:703–706PubMedCrossRef Mizuki N, Meguro A, Ota M et al (2010) Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet 42:703–706PubMedCrossRef
58.
Zurück zum Zitat Seyahi E, Ozdogan H (2010) Juvenile Behçet's syndrome. In: Yazici Y, Yazici H (eds) Behçet's syndrome, 1st edn. Springer, New York, pp 205–214CrossRef Seyahi E, Ozdogan H (2010) Juvenile Behçet's syndrome. In: Yazici Y, Yazici H (eds) Behçet's syndrome, 1st edn. Springer, New York, pp 205–214CrossRef
59.
Zurück zum Zitat de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, Boomsma DI (2005) Heritability estimates of innate immunity: an extended twin study. Genes Immun 6:167–170PubMedCrossRef de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, Boomsma DI (2005) Heritability estimates of innate immunity: an extended twin study. Genes Immun 6:167–170PubMedCrossRef
Metadaten
Titel
Behçet Syndrome: Is It One Condition?
verfasst von
H. Yazici
S. Ugurlu
E. Seyahi
Publikationsdatum
01.12.2012
Verlag
Humana Press Inc
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 3/2012
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-012-8319-x

Weitere Artikel der Ausgabe 3/2012

Clinical Reviews in Allergy & Immunology 3/2012 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.